Product Information |
|||||||
Biological Activity |
|||||||
MK-2206 dihydrochloride (MK-2206 (2HCl)) is an orally active allosteric AKT inhibitor with IC50s of 5 nM, 12 nM, and 65 nM for AKT1, AKT2, and AKT3, respectively[1]. |
|||||||
Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines) |
|||||||
Species |
Mouse |
Rat |
Rabbit |
Guinea pig |
Hamster |
Dog |
|
Weight (kg) |
0.02 |
0.15 |
1.8 |
0.4 |
0.08 |
10 |
|
Body Surface Area (m2) |
0.007 |
0.025 |
0.15 |
0.05 |
0.02 |
0.5 |
|
Km factor |
3 |
6 |
12 |
8 |
5 |
20 |
|
Animal A (mg/kg) = Animal B (mg/kg) multiplied by (Animal B Km / Animal A Km) |
|||||||
Order Information |
|||||||
|
|
Quantity |
Price($) |
Price($) |
Availability |
||
|
|
|
|
5mg |
$115.00 |
€126.50 |
In stock |
|
|
|
|
10mg |
$165.00 |
€181.50 |
In stock |
|
|
|
|
50mg |
$385.00 |
€423.50 |
In stock |
|
|
|
|
Free Delivery on orders over $350.00. |
|||
Chemical Information |
|||||||
Molecular Weight |
480.39 |
||||||
Formula |
C25H21N5O.2HCl |
||||||
CAS Number |
1032350-13-2 |
||||||
Purity |
>98.00% |
|
|
|
|
|
|
Solubility |
¡Ý 12.01mg/mL in DMSO |
||||||
Storage |
at -20¡ãC |
|
|
|
|
|
|
Reference |
|||||||
[1]. Zhao YY, et al. Effects of an oral allosteric AKT inhibitor (MK-2206) on human nasopharyngeal cancer in vitro and in vivo. Drug Des Devel Ther. 2014 Oct 10;8:1827-37. |
|||||||
We Devoted Ourselves To The Development Of Biomedical Research Reage nt. |
|||||||